hotspot -WSS

hotspot

author：entertainment 2025-09-27 12:55:24 - browse：87443

PORTRAIT of Michelle Monje smiling with trees in the background. -- health coverage from STAT. — New research led by Stanford neuro-oncologist Michelle Monje shines light on the electrochemical signaling pathway between neurons and cancer cells. Courtesy MacArthur Foundation

The idea that cancer can hijack brain plasticity — subverting supple connections in the healthy brain that ordinarily lead to learning and memory formation — is gaining traction.

First reported in Cell in 2015, research led by Stanford neuro-oncologist Michelle Monje showed that active nerve cells could promote the growth of high-grade gliomas, a form of brain cancer with a poor prognosis. Four years later, her lab revealed in a Nature paper that synapses between these neurons and gliomas spurred tumor growth, and last year, the team demonstrated how these same synapses revved up glioblastoma’s spread.

There are still many questions about precisely how this process unfolds, and it’s too soon to say how solutions might be reached. But in a new paper published in Nature on Wednesday, Monje’s team solves another part of the puzzle, shining light on the electrochemical signaling pathway between neurons and cancer cells.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Wikipedia

WSS

Kaiser's Risant Health gobbled up Geisinger. Who is next?

STAT Readout Newsletter: Today in biotech, life science news

With trial win, GSK could get blood cancer drug back on market

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

What the Wegovy shortage looks like for doctors — and for patients

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

hotspot

hotspot

entertainment

Apple is now the first public company to be valued at $3 trillion

European regulators recommend Amylyx's ALS drug be rejected

Activists slam private health insurers over coverage restrictions

Change Healthcare can notify patients about the breach, HHS says

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

STAT Readout: Today's biotech news includes Sana and Amylyx

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How doctors and nurses shape Google's AI

BioMarin wins approval for gene therapy to treat hemophilia A

What the Wegovy shortage looks like for doctors — and for patients

Wikipedia

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Woman returns to dialysis after doctors remove transplanted pig kidney

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

STAT Readout: Today's biotech news includes Sana and Amylyx

Takeaways from AdvaMed, the largest medical devices conference

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

hotspot

Wikipedia

leisure time

focus